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Characterization and Crystal Structure of a Robust Cyclohexanone
Monooxygenase
Elvira Romero+, J. Rubn Gmez Castellanos+, Andrea Mattevi,* and Marco W. Fraaije*
Abstract: Cyclohexanone monooxygenase (CHMO) is
a promising biocatalyst for industrial reactions owing to its
broad substrate spectrum and excellent regio-, chemo-, and
enantioselectivity. However, the low stability of many Baeyer–
Villiger monooxygenases is an obstacle for their exploitation in
industry. Characterization and crystal structure determination
of a robust CHMO from Thermocrispum municipale is
reported. The enzyme efficiently converts a variety of aliphatic,
aromatic, and cyclic ketones, as well as prochiral sulfides. A
compact substrate-binding cavity explains its preference for
small rather than bulky substrates. Small-scale conversions
with either purified enzyme or whole cells demonstrated the
remarkable properties of this newly discovered CHMO. The
exceptional solvent tolerance and thermostability make the
enzyme very attractive for biotechnology.
Cyclohexanone monooxygenase (CHMO; EC 1.14.13.22) is
an FAD- and NADPH-dependent Baeyer–Villiger monoox-
ygenase (BVMO).[1] A wide variety of ketones are converted
by CHMO into esters or lactones through the insertion of an
oxygen atom on one side or the other of the carbonyl group.
In addition, CHMO oxidizes aldehydes and heteroatoms[2]
and carries out epoxidation reactions.[3] In contrast to conven-
tional Baeyer–Villiger oxidations using peracids, CHMO
reactions are environmentally friendly and often proceed
with excellent regio-, chemo-, and enantioselectivity.[4]
Numerous industrial applications have been suggested for
CHMO.[5] The conversion of cyclohexanone as catalyzed by
CHMO is of particular interest since the product, e-capro-
lactone, is a precursor of both adipic acid and e-caprolactam,[6]
which are known polymer building blocks.[7] One of the main
barriers to exploiting CHMO as a biocatalyst is its lack of
stability.[8] To date, the best-characterized CHMOs are from
Acinetobacter calcoaceticus NCIMB 9871 (AcCHMO) and
Rhodococcus sp. HI-31 (RhCHMO). Similar CHMOs have
been identified from various bacteria (Table S1 in the
Supporting Information). However, engineering attempts to
improve their stability have met with limited success.[9] The
only robust BVMO described so far, phenylacetone mono-
oxygenase from Thermobifida fusca (TfPAMO; EC
1.14.13.92), shows no activity on cyclohexanone.[10] Our
interest in using a robust BVMO to produce e-caprolactone
and other valuable compounds prompted us to search for
a stable CHMO in the available genomes of thermophiles.
Among the retrieved sequences, a putative CHMO from
Thermocrispum municipale DSM 44069 was found
(TmCHMO; NCBI RefSeq: WP_028849141.1). This thermo-
philic organism was isolated from municipal waste com-
post.[11] TmCHMO clusters with known CHMOs sequences
(Figures S1,S2 in the Supporting Information), the closest
homologue being from Brachymonas petroleovorans (66%
sequence identity). We identified three genes upstream of the
TmCHMO gene that may participate in cyclohexanol degra-
dation (Table S2). These sequence analyses suggested that the
T. municipale enzyme may be a robust CHMO.
Therefore, we purified TmCHMO and studied its sub-
strate acceptance (Figure S3).[4,12] For the sake of comparison,
the same analysis was performed with AcCHMO. Small
aliphatic ketones such as cyclohexanone, cyclobutanone, and
bicyclo[3.2.0]hept-2-en-6-one were efficiently converted by
both CHMOs, although in all cases, the Km values for
AcCHMO were higher than those measured for TmCHMO,
despite similar kcat values (Table S3). Conversely, the bulkier
molecules progesterone and cyclopentadecanone were not
substrates of either enzyme.[13] At high substrate concentra-
tions, substrate inhibition was observed for TmCHMO, which
is not unprecedented for this enzyme class (Figure S4). To
avoid decreased conversions as a result of this effect, reaction
media with two phases have been successfully implemented.[5]
The uncoupling rate for both CHMOs was around 0.1 s1. To
compare their thermostability, the ThermoFAD method was
used as a first approach.[14] This confirmed that AcCHMO is
only moderately stable since it exhibits a Tm value of 37 8C
(Table S4).[9a,b] Conversely, the Tm value for TmCHMO was
found to be 11 8C higher. Next, the two CHMOs were probed
for their resistance to thermal inactivation (Figure 1A). This
revealed that TmCHMO still displayed 58% residual activity
after 5.5 h at 45 8C. By contrast, AcCHMO lost its activity
within a few minutes at 45 8C. These experiments were
complemented by analyzing the effect of cosolvents on the
stability, since enzymes working in organic solvents or
aqueous/organic mixtures are often desired for biotech-
nology.[15] While AcCHMO essentially lost its activity after
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25 min incubation in 14% acetonitrile at 20 8C, TmCHMO
remained highly active (> 80%) for at least 20 h under these
conditions (Figure 1B). These thermostability and solvent-
tolerance data clearly show that TmCHMO is a substantially
more robust biocatalyst than AcCHMO.
Besides influencing stability, the reaction medium can also
modify enzyme selectivity.[15–16] The effect of cosolvents
(Table S5) was determined by using 2-butanone, the con-
version of which to two possible regioisomers is of industrial
interest (Scheme S1).[17] All reactions were stopped after 48 h
at 17 8C. The ratio between the products methyl propanoate
and ethyl acetate was found to be about 3:7 for both purified
TmCHMO and AcCHMO in the absence of any cosolvent
(Figure S5). The same regioisomer ratio was observed using
whole cells of Escherichia coli expressing one or the other
CHMO (not shown). Next, we inspected the effect of various
solvents at 15% concentration. The two purified CHMOs
exhibited similar results, although the yields of TmCHMO
were generally higher. The strongest effect on regioselectivity
was observed with 2-methyl-1,3-dioxolane, which led to
almost exclusive production of ethyl acetate. 1,3-Dioxane
and 1,4-dioxane had a more moderate influence, since about
40% of the total product was methyl propanoate. We also
carried out reactions with 30% methanol or ethanol. These
cosolvents had a negligible effect on enzyme regioselectivity.
However, they considerably decreased the 2-butanone con-
version yield for AcCHMO (< 4%), while that for
TmCHMO remained high (96% and 56% for methanol and
ethanol, respectively). From these results, it can be concluded
that the robustness of TmCHMOmakes possible to modulate
its regioselectivity through using cosolvents.
Along the lines of the previous experiments, the potential
of TmCHMO as a regioselective biocatalyst was further
probed by using rac-bicyclo[3.2.0]hept-2-en-6-one. This com-
pound can be converted by BVMOs into four products
(Scheme S2). This reaction is widely used to study the ability
of BVMOs to carry out the kinetic resolution of racemic
compounds,[18] and it is of interest for the synthesis of
prostaglandins, for example.[19] Small-scale conversions of
rac-bicyclo[3.2.0]hept-2-en-6-one were carried out with
TmCHMO, AcCHMO, and TfPAMO. Both enantiomers of
this ketone were fully converted by both CHMOs, yielding
almost exclusively one regioisomer from each enantiomer
(Figure S6A and Table S6).[20] By contrast, TfPAMO pro-
duced all four possible lactones, proving to be far less
regioselective than CHMOs. We also used the same
BVMOs to produce enantiomerically pure sulfoxides, which
are widely used in asymmetric synthesis and are often
biologically active.[21] The prochiral compound thioanisole
was chosen as a model substrate (Scheme S3). The CHMOs
exclusively produced the (R)-sulfoxide, whereas TfPAMO
produced both enantiomers, leading to an ee of only 16% for
the (R)-sulfoxide (Figure S6B, Table S6).[18c,22]
Having established that TmCHMO is an appealing
biocatalyst based on its thermostability, solvent tolerance,
and selectivity, we performed a more in-depth character-
ization of its mechanistic properties. The reaction mechanism
of a BVMO generally involves a C4a-peroxyflavin intermedi-
ate that forms a tetrahedral Criegee intermediate through
nucleophilic attack on the substrate carbonyl carbon
(Scheme S4). Rearrangement of the Criegee intermediate
yields the ester or lactone product.[23] The spectral changes for
TmCHMO during its catalytic cycle were monitored using
a stopped-flow spectrophotometer. Anaerobic reaction of
TmCHMO with NADPH resulted in the loss of the absorb-
ance peaks at 376 nm and 440 nm, which is consistent with the
formation of the two-electron-reduced enzyme. After mixing
the reduced TmCHMO with air-saturated buffer, a rapid
increase in absorbance at 355 nm was observed (k= 37 s1),
together with a small absorbance decrease at 450 nm (Fig-
ure 2A). These spectral changes are indicative of the
formation of the C4a-peroxyflavin intermediate. The absorb-
ance at 355 nm was stable for 3 s and then slowly decreased
(k= 0.01 s1) owing to decay of the intermediate, which is
consistent with hydrogen peroxide elimination to form the
reoxidized enzyme (k= 0.004 s1). In a second set of experi-
ments, the anaerobically reduced TmCHMO was mixed with
cyclohexanone in air-saturated buffer. The absorbance at
355 nm increased for 0.1 s and then immediately decreased,
which demonstrates the low kinetic stability of the inter-
mediate in the presence of cyclohexanone (Figure 2B and
Figure S7). The rate of formation of the peroxyflavin was not
influenced by the presence of cyclohexanone, while its decay
rate was 80-fold higher than that measured in the absence of
this ketone. Collectively, these experiments suggest that
TmCHMO functions as a typical BVMO, forming a stable
flavin peroxide that can effectively perform substrate oxy-
genation. The kinetic stability of the peroxyflavin enables the
enzyme to efficiently couple NADPH and dioxygen con-
sumption with substrate oxygenation without leakage of
hydrogen peroxide, which can be harmful in the context of
large-scale biotransformations.[23a–c]
For a more in-depth understanding of TmCHMO proper-
ties, its crystal structure in complex with FAD and NADP+ in
the oxidized and reduced states were solved to a resolution of
1.22 and 1.60  (Table S7; Figure 3A, and Figure S8). In an
attempt to rationalize the relatively high thermostability, we
Figure 1. Effect of temperature and acetonitrile (ACN) on the stability
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investigated the number of salt bridges present, since they are
known to contribute to the thermostability of proteins.[24] Our
computational analysis of TfPAMO, TmCHMO, and
RhCHMO identified 37, 31, and 16 salt bridges, respectively
(Figure S9). This finding correlates with their Tm values (61,
48, and 37 8C, respectively). Mutagenesis on these BVMOs
will be carried out to confirm the role of salt bridges in their
stability.
The overall structures of the oxidized and reduced forms
share an almost identical conformation, with a root mean
square deviation of 0.20  for the backbone Ca atoms.
However, inspection of the active sites shows distinct alter-
ations (Figure 3B and Figure S10). In the reduced enzyme,
the electron density corresponding to the nicotinamide
moiety of NADP+ is disordered, with no well-defined
electron density. Furthermore, R329 of the oxidized enzyme
is engaged in H-bonds with the carboxamide group of NADP+
and the side chain of D59. Upon enzyme reduction, R329
moves away from NADP+ and points toward the isoallox-
azine moiety of the flavin ring, which favors an electrostatic
interaction between the positively charged guanidinium
group of R329 and the negatively charged reduced flavin.
Upon formation of the flavin peroxide and concomitant loss
of the negative charge on the flavin ring, R329 would shift
back to the conformation interacting with the NADP+,
thereby making the catalytic center accessible to a ketone
substrate.[23d] These results confirm that the formation of the
negatively charged reduced flavin is associated with a local-
ized rearrangement of the central elements of the catalytic
site. NADP+ is required for peroxyflavin formation and
stabilization, primarily to provide essential H-bonding inter-
actions.
Inspecting the electron density of the oxidized structure of
TmCHMO revealed that the putative substrate-binding
pocket is occupied by a ring-shaped ligand (Figure 4A and
Figure S11). This region of electron density was putatively
assigned to a molecule of nicotinamide, possibly resulting
from the degradation of NADP+. Specifically, the ligand is
placed right in front of the flavin ring and is in contact with
residues T60, L145, L428, P430, F434, T435, and L437. This
arrangement is very similar to that observed in the structures
of RhCHMOtight
[23e] and TfPAMOMES,
[23d] both with a bound
ligand (Figure 4B and Figure S12). The ligand-binding site is
a compact cavity, which explains the general preference of
TmCHMO for medium/small substrates.
To conclude, we report the discovery of a robust CHMO
that shows great promise as an oxidative biocatalyst. The
enzyme was found to be much more thermostable and solvent
tolerant than known CHMOs. Furthermore, having estab-
lished an effective recombinant production system and
elucidated its crystal structure, TmCHMO provides the
perfect starting point for engineering approaches to tune its
properties.
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a Robust Cyclohexanone Monooxygenase
Looking like a true survivor : The discov-
ery of a robust cyclohexanone monooxy-
genase (CHMO) that shows great prom-
ise as an oxidative biocatalyst is reported.
This enzyme (TmCHMO) efficiently con-
verts a variety of aliphatic, aromatic, and
cyclic ketones, as well as prochiral sul-
fides, and was found to be much more
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